FDA-Device2017-04-26Class II
Proteus 235, Proton Therapy System
Ion Beam Applications S.A.
Hazard
In specific circumstances, the user is able to restart an aborted irradiation without having to select the correct partial irradiation data.
Sold states
Distribution in US (to Louisiana), and France.
Affected count
2 worldwide, 1 in U.S.
Manufactured in
Chemin du Cyclotron, 3, N/A, Louvain La Neuve, N/A, Belgium
Products
Proteus 235, Proton Therapy System
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1830-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief